Literature DB >> 19093177

Contemporary management of muscle-invasive bladder cancer.

Faysal A Yafi1, Jordan R Steinberg, Wassim Kassouf.   

Abstract

Over the past decade, there have been a number of substantial changes in the treatment of invasive bladder cancer. Muscle-invasive bladder cancer is an aggressive disease that often presents at an advanced stage with or without distant metastases. The potential for cure is highest when the disease is confined to the bladder. Optimal management depends on our understanding of disease biology, refinements to our clinical staging, and improvements in the quality of treatment. This review will focus on the contemporary management of muscle-invasive urothelial carcinoma of the bladder and will discuss the role of radical cystectomy, extended lymphadenectomy, neoadjuvant/ adjuvant chemotherapy, and various forms of bladder-preservation strategies.

Entities:  

Mesh:

Year:  2008        PMID: 19093177     DOI: 10.1007/s10147-008-0788-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  44 in total

1.  Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2.

Authors:  Amir Sherif; Erkki Rintala; Oddvar Mestad; Jonas Nilsson; Lars Holmberg; Sten Nilsson; Per-Uno Malmström
Journal:  Scand J Urol Nephrol       Date:  2002

2.  Advances in the etiology of urothelial cancer.

Authors:  A S Morrison
Journal:  Urol Clin North Am       Date:  1984-11       Impact factor: 2.241

3.  Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study.

Authors:  M Stöckle; W Meyenburg; S Wellek; G Voges; U Gertenbach; J W Thüroff; C Huber; R Hohenfellner
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

4.  Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.

Authors:  Wassim Kassouf; David Swanson; Ashish M Kamat; Dan Leibovici; Arlene Siefker-Radtke; Mark F Munsell; H Barton Grossman; Colin P N Dinney
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

5.  P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.

Authors:  Wassim Kassouf; Philippe E Spiess; Gordon A Brown; Mark F Munsell; H Barton Grossman; Arlene Siefker-Radtke; Colin P N Dinney; Ashish M Kamat
Journal:  Eur Urol       Date:  2007-04-10       Impact factor: 20.096

6.  The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.

Authors:  W Duncan; P M Quilty
Journal:  Radiother Oncol       Date:  1986-12       Impact factor: 6.280

7.  Alternating chemo-radiotherapy in bladder cancer: a conservative approach.

Authors:  M Orsatti; A Curotto; L Canobbio; D Guarneri; D Scarpati; M Venturini; P Franzone; S Giudici; G Martorana; F Boccardo
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

8.  Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.

Authors:  Joachim Leissner; Christiane Koeppen; Helmut K Wolf
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

9.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Authors:  Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

10.  The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.

Authors:  D G Skinner; J R Daniels; C A Russell; G Lieskovsky; S D Boyd; P Nichols; W Kern; J Sakamoto; M Krailo; S Groshen
Journal:  J Urol       Date:  1991-03       Impact factor: 7.450

View more
  5 in total

1.  Brachytherapy-based bladder sparing alternative to cystectomy.

Authors:  Elie Antebi; Murugesan Manoharan; Mark S Soloway
Journal:  Nat Rev Urol       Date:  2009-11       Impact factor: 14.432

2.  Lymph node metastasis mapping in extended lymphadenectomy to the level of the inferior mesenteric artery for bladder cancer.

Authors:  Hiroshi Kitamura; Fumiyasu Takei; Sachiyo Nishida; Takashi Muranaka; Naoya Masumori; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2011-05-25       Impact factor: 3.402

Review 3.  Role of lymph node dissection in management of bladder cancer.

Authors:  Hiroshi Kitamura; Naoya Masumori; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2011-04-28       Impact factor: 3.402

4.  Lymph node density in muscle-invasive transitional cell carcinoma of the urinary bladder; De novo versus progressive disease.

Authors:  Ahmed Elabbady; Mohamed Mohieeldin Hashad; Ahmed Fouad Kotb; Dina Mohamed Abdullah; Ahmad Beltagy
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jul-Sep

5.  ERAS vs. Traditional Protocol in Patients Who Had Radical Cystectomy with Ileal Conduit: A Retrospective Comparative Analysis of 182 Cases.

Authors:  Ahmet Semih Guleser; Yasar Basaga
Journal:  Adv Urol       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.